Summary

● The company has solid fundamentals for a short-term investment strategy.


Strengths

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The stock, which is currently worth 2020 to 0.07 times its sales, is clearly overvalued in comparison with peers.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company has insufficient levels of profitability.

● The company's earnings releases usually do not meet expectations.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Analysts covering the stock have recently lowered their earnings forecast.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the past year, analysts have significantly revised downwards their profit estimates.

● The underlying tendency is negative on the weekly chart below the resistance at 16.9 EUR